Recent Finacing
Recent Raise
Gameto engineers iPSC-derived ovarian support cells and an AI-powered in vitro organoid platform to mature oocytes ex vivo (Fertilo), running multinational clinical use and a U.S. Phase 3 trial.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
